Most cited papers from Neurophyxia (Netherlands)

Neurophyxia (Netherlands)

What are the most cited papers from Neurophyxia (Netherlands)?

The most cited paper from Neurophyxia (Netherlands) is "Neuroprotective strategies following perinatal hypoxia-ischemia: Taking aim at NOS" (Martin Albrecht, Karina Zitta, Floris Groenendaal et al., 2019), with 53 citations. Next come "A differential diagnostic problem ?" (37) and "Short-Term Dose–Response Characteristics of 2-Iminobiotin Immediately Postinsult in the Neonatal Piglet After Hypoxia-Ischemia" (24).

Published TypeFieldAccess

Showing 21 of 21 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Neuroprotective strategies following perinatal hypoxia-ischemia: Taking aim at NOS Martin Albrecht, Karina Zitta, Floris Groenendaal et al. · Free Radical Biology and Medicine Open access	25 Feb 2019	53
2	A differential diagnostic problem ? H. E. Loggers, Jan C. Oosterwijk, W. C. G. Overweg‐Plandsoen et al. · Ophthalmic Paediatrics and Genetics	1992	37
3	Short-Term Dose–Response Characteristics of 2-Iminobiotin Immediately Postinsult in the Neonatal Piglet After Hypoxia-Ischemia Stella Tracey Bjorkman, Zoe Ireland, Xiyong Fan et al. · Stroke Open access	30 Jan 2013	24
4	A Systematic Review of Musculoskeletal Mobilization and Manipulation Techniques Used in Veterinary Medicine Kevin K. Haussler, Amie Lamoreaux Hesbach, Laura Romano et al. · Animals ReviewOpen access	24 Sep 2021	23
5	Pharmacokinetics and short-term safety of the selective NOS inhibitor 2-iminobiotin in asphyxiated neonates treated with therapeutic hypothermia Laurent M. A. Favié, Cacha M. P. C. D. Peeters‐Scholte, Anouk T. M. de Bakker et al. · Pediatric Research Open access	2 Oct 2019	17
6	2-Iminobiotin Superimposed on Hypothermia Protects Human Neuronal Cells from Hypoxia-Induced Cell Damage: An in Vitro Study Karina Zitta, Cacha M. P. C. D. Peeters‐Scholte, Lena Sommer et al. · Frontiers in Pharmacology Open access	11 Jan 2018	11
7	Insights into the neuroprotective mechanisms of 2-iminobiotin employing an in-vitro model of hypoxic-ischemic cell injury Karina Zitta, Cacha M. P. C. D. Peeters‐Scholte, Lena Sommer et al. · European Journal of Pharmacology	23 Oct 2016	10
8	Concurrent Validity of Equine Joint Range of Motion Measurement: A Novel Digital Goniometer versus Universal Goniometer Anna Bergh, Nicole Gandre Lauridsen, Amie Lamoreaux Hesbach · Animals Open access	19 Dec 2020	9
9	A Phase IIa Clinical Trial of 2-Iminobiotin for the Treatment of Birth Asphyxia in DR Congo, a Low-Income Country Thérèse Biselele, Jephté Bambi, D.-M. Betukumesu et al. · Pediatric Drugs	21 Jan 2020	9
10	Physical activity and sport-specific training patterns in Swedish sporting and working trial dogs—A questionnaire survey Ann Essner, Amie Lamoreaux Hesbach, Helena Igelström et al. · Frontiers in Veterinary Science Open access	Nov 2022	8
11	First-in-Human Study of the Safety, Tolerability, Pharmacokinetics and - Preliminary Dynamics of Neuroprotectant 2-Iminobiotin in Healthy Subjects Ewoud‐Jan van Hoogdalem, Cacha M. P. C. D. Peeters‐Scholte, Paul W.T.J. Leufkens et al. · Current Clinical Pharmacology Open access	18 Oct 2019	7
12	Dog Handler Beliefs regarding Barriers and Facilitators to Canine Health Promotion and Injury Prevention in Swedish Working Dog Trials and Competitions Ann Essner, Catarina Kjellerstedt, Amie Lamoreaux Hesbach et al. · Veterinary Sciences Open access	21 May 2022	5
13	Observational study shows that it is feasible to provide neuroprotective treatment for neonatal encephalopathy in low‐income countries Thérèse Biselele, Jephté Bambi, Gunnar Naulaers et al. · Acta Paediatrica Open access	9 Feb 2018	5
14	Neuroprotection after cardiac arrest with 2-iminobiotin: a single center phase IIa study on safety, tolerability, and pharmacokinetics Marjolein M. Admiraal, Daan C. Velseboer, Huibert Tjabbes et al. · Frontiers in Neurology Open access	2 Jun 2023	4
15	Safety, Tolerability, and Pharmacokinetics of the Neuroprotectant 2-Iminobiotin in Patients With Large-Vessel Occlusion Ischemic Stroke Treated With Endovascular Thrombectomy Erik M. Vos, Cacha M. P. C. D. Peeters‐Scholte, Jelis Boiten et al. · Stroke Open access	28 Jul 2025	2
16	2-iminobiotin, a selective inhibitor of nitric oxide synthase, improves memory and learning in a rat model after four vessel occlusion, mimicking cardiac arrest Cacha M. P. C. D. Peeters‐Scholte, Sigal Meilin, Yafit Berckovich et al. · PLoS ONE Open access	25 Sep 2023	2
17	The possibilities of using elastic therapeutic (Kinesio) tape in patients with scoliosis Esther De Ru · Scoliosis Open access	Dec 2014	2
18	Translation from animal to clinical studies, choosing the optimal moment Laurent M. A. Favié, Cacha M. P. C. D. Peeters‐Scholte, Anouk T. M. de Bakker et al. · Pediatric Research Open access	19 Feb 2020	1
19	Endovascular treatment in patients with renal dysfunction: results of the MR CLEAN Registry Erik M. Vos, Cacha M P C D Peeters-Scholte, Sanne J. den Hartog et al. · European Stroke Journal Open access	Mar 2026	0
20	302 Seizure Burden and Neurobehavioral Scores after Therapeutic Hypothermia in the Newborn Piglet Fan Xu, Cacha M. P. C. D. Peeters‐Scholte, Nigel Ward et al. · Archives of Disease in Childhood Open access	Oct 2012	0
21	Everything You May Know is Indeed Half True Athanasios Pantavos · Advances in Obesity Weight Management & Control Open access	7 May 2015	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.